Portside Wealth Group LLC Has $3.19 Million Stock Holdings in Intuitive Surgical, Inc. $ISRG

Key Points

• Portside Wealth Group increased its stake in Intuitive Surgical (NASDAQ:ISRG) by 185.3% in Q4 to 5,623 shares valued at about $3.19 million.
• Insiders have been net sellers recently — 32,943 shares worth roughly $17.28 million were sold in the last 90 days, including large sales by SVP Mark Brosius and Director Gary Guthart, leaving insiders with about 0.60% ownership.
• Operational and analyst snapshot: Intuitive beat Q4 estimates with EPS of $2.53 and revenue of $2.87 billion (up 18.8% year-over-year), and analysts hold a consensus rating of "Moderate Buy" with a $611.77 price target.

Portside Wealth Group LLC raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 185.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,623 shares of the medical equipment provider's stock after acquiring an additional 3,652 shares during the quarter. Portside Wealth Group LLC's holdings in Intuitive Surgical were worth $3,185,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Holos Integrated Wealth LLC acquired a new stake in Intuitive Surgical in the fourth quarter valued at approximately $25,000. Olistico Wealth LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter worth about $28,000. Greykasell Wealth Strategies Inc. acquired a new stake in shares of Intuitive Surgical in the third quarter worth about $27,000. Caitlin John LLC acquired a new stake in shares of Intuitive Surgical in the third quarter worth about $30,000. Finally, Riggs Asset Managment Co. Inc. lifted its position in shares of Intuitive Surgical by 84.2% in the second quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider's stock worth $38,000 after buying an additional 32 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

ISRG has been the subject of a number of analyst reports. Truist Financial boosted their price target on Intuitive Surgical from $620.00 to $650.00 and gave the stock a "buy" rating in a research report on Thursday, December 18th. Argus reduced their price target on Intuitive Surgical from $630.00 to $560.00 and set a "buy" rating for the company in a research report on Wednesday, February 4th. Robert W. Baird reduced their price target on Intuitive Surgical from $655.00 to $645.00 and set an "outperform" rating for the company in a research report on Friday, January 23rd. Wall Street Zen cut shares of Intuitive Surgical from a "buy" rating to a "hold" rating in a research note on Saturday, February 7th. Finally, Sanford C. Bernstein boosted their price objective on shares of Intuitive Surgical from $740.00 to $750.00 and gave the stock an "outperform" rating in a research note on Friday, January 23rd. One research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $611.77.

Insider Buying and Selling at Intuitive Surgical

In related news, SVP Mark Brosius sold 2,362 shares of the company's stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $498.68, for a total transaction of $1,177,882.16. Following the completion of the transaction, the senior vice president directly owned 3,554 shares in the company, valued at $1,772,308.72. This represents a 39.93% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Gary S. Guthart sold 24,500 shares of the company's stock in a transaction on Tuesday, January 27th. The shares were sold at an average price of $530.10, for a total transaction of $12,987,450.00. Following the transaction, the director owned 3,694 shares of the company's stock, valued at approximately $1,958,189.40. The trade was a 86.90% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 32,943 shares of company stock worth $17,279,568 in the last ninety days. 0.60% of the stock is owned by insiders.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $452.58 on Tuesday. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $603.88. The stock has a market capitalization of $160.72 billion, a PE ratio of 57.36, a P/E/G ratio of 3.49 and a beta of 1.68. The stock has a 50-day simple moving average of $485.91 and a 200 day simple moving average of $514.33.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The business had revenue of $2.87 billion during the quarter, compared to analysts' expectations of $2.72 billion. During the same quarter in the previous year, the firm earned $2.21 EPS. The firm's revenue was up 18.8% compared to the same quarter last year. As a group, equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.